Reported 40,000 shares, unchanged from the prior quarter.
Reported value -45.6%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2023-12-31 | 3232 |
| 2024-03-31 | 6400 |
| 2024-06-30 | 3480 |
| 2024-09-30 | 2828 |
| 2024-12-31 | 4000 |
| 2025-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2025 | Reduced | 0 | -40,000 (-100.0%) | 0 | $0 | 2025-05-08 | |
| Q4 2024 | Unchanged | 40,000 | 0 (0.0%) | < 0.01% | $4,000 | 2025-02-03 | |
| Q3 2024 | Unchanged | 40,000 | 0 (0.0%) | < 0.01% | $2,828 | 2024-11-05 | |
| Q2 2024 | Unchanged | 40,000 | 0 (0.0%) | < 0.01% | $3,480 | 2024-08-13 | |
| Q1 2024 | Unchanged | 40,000 | 0 (0.0%) | < 0.01% | $6,400 | 2024-05-15 | |
| Q4 2023 | New | 40,000 | +40,000 (0.0%) | < 0.01% | $3,232 | 2024-02-12 |
Who else reported the position
33 managers reported NKGEN BIOTECH INC for Q2 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Atalaya Capital Management LP | Unchanged | 30,000 | 0 | < 0.01% | $3,600,000 | 3 qtrs |
| RIVERNORTH CAPITAL MANAGEMENT LLC | Unchanged | 652,432 | 0 | < 0.01% | $65,243 | 3 qtrs |
| BNP PARIBAS FINANCIAL MARKETS | Unchanged | 150,000 | 0 | < 0.01% | $14,805 | 2 qtrs |
| ADAGE CAPITAL PARTNERS GP L L C | Reduced | 161,325 | -20,475 | < 0.01% | $14,035 | 3 qtrs |
| Balyasny Asset Management LLC | Unchanged | 139,893 | 0 | < 0.01% | $13,849 | 3 qtrs |
| Exos Asset Management LLC | Unchanged | 146,254 | 0 | 0.02% | $13,326 | 2 qtrs |
| Shaolin Capital Management LLC | Unchanged | 128,274 | 0 | < 0.01% | $11,160 | 3 qtrs |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | Unchanged | 100,000 | 0 | < 0.01% | $9,900 | 3 qtrs |
| KIM LLC | Unchanged | 92,040 | 0 | < 0.01% | $9,112 | 3 qtrs |
| JANE STREET GROUP LLC | Unchanged | 100,165 | 0 | < 0.01% | $8,714 | 3 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2024
- Filed
- August 13, 2024
- Filing type
- 13F-HR
- Position type
- *W EXP 05/31/202
Voting authority reported
- Sole
- 40,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.